Real-time enrollment status for this advanced unresectable gastric adenocarcinoma clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 3:56 PM UTC
| NCT Number | NCT07554521 |
| Recruiting Status | Recruiting |
| Condition | Advanced Unresectable Gastric Adenocarcinoma |
| Phase | Clinical Trial |
| Target Enrollment | 30 participants |
| Active Locations | 5 sites in the US |
| Sponsor | BeOne Medicines |
| Last Updated on CT.gov | July 9, 2026 (4 days ago) |
As of July 13, 2026: Clinical trial NCT07554521 is currently recruiting participants. This clinical trial study for advanced unresectable gastric adenocarcinoma is actively seeking new participants at 5 locations across the United States. The study is sponsored by BeOne Medicines. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07554521 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 5 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07554521 was last updated 4 days ago (July 9, 2026). HelloStudys verifies this status automatically.